the concern I have is that on May 1 they stated that the Teva portfolio was broadly in line with expectations, that being EBITDA of 6 times acquisition price, I have that at $109m.
now today they are forecasting EBITDA on Teva of $94.5m, that seems a very steep drop off in two months?
I'm happy to be corrected, quick calcs on my part.
the concern I have is that on May 1 they stated that the Teva...
-
- There are more pages in this discussion • 272 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MYX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$4.61 |
Change
-0.050(1.07%) |
Mkt cap ! $392.1M | |||
| Open | High | Low | Value | Volume |
| $4.63 | $4.70 | $4.55 | $667.6K | 144.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 171 | $4.59 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $4.63 | 171 | 1 |
View Market Depth
| Last trade - 16.10pm 21/06/2024 (20 minute delay) ? |
| MYX (ASX) Chart |